A portable molecular laboratory for rapid genotyping in the field: a feasibility study for sickle cell disease
Frontiers in Genetics · 19.11.2026 · 17
DOI: 10.3389/fgene.2026.1999369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Genetics, online erschienen am 19.11.2026. Verfasst von Fabienne Grunder und 8 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) is the most common recessive genetic disorder, caused by pathogenic variants of the HBB gene. SCD is associated with vaso-occlusive crises, infections, and severe anaemia, which contribute to increased morbidity and mortality. Pathogenic HBB alleles are particularly common in Sub-Saharan Africa, where up to 25% of the population is heterozygous carriers. Although HBB gene sequencing provides accurate molecular diagnosis, access to DNA analysis and sequencing remains limited in many low- and middle-income countries (LMICs), where SCD prevalence is highest. Improved access to genetic profiling is important for both individual patient care and public health planning.
Aim
This feasibility study aimed to demonstrate that a portable medical genetics laboratory can be used to genotype individuals for the HBB A, S, and C alleles and their combinations within a few hours outside of a laboratory setting. Methods and Results We established a portable medical genetics laboratory capable of DNA extraction and isothermal DNA amplification using a commercially available kit for the A, S, and C alleles of the HBB gene. The laboratory was deployed during the annual meeting of the Swiss Association of Patients with SCD. Buccal swabs and dried blood spots (DBS) were collected from 28 participants with a documented HBB status; one was excluded post hoc , leaving 27 for analysis. Initial genotype results for all participants were obtained within five hours of sample collection. One participant showed the expected buccal–DBS discordance due to post-transplant donor chimerism. In the other 26, first-pass concordance was 23/26 (88.5%; 95% CI 71.0%–96.0%); the three discrepancies were resolved by repeat testing of the original lysates 2–4 days later (final concordance 26/26, 100%; 95% CI 87.1%–100%). No independent reference method was used, so diagnostic accuracy was not assessed.
Conclusion
This study shows that HBB genotyping using a portable genetic laboratory is operationally feasible in a community setting. Its diagnostic accuracy remains to be established against a reference method. Once validated, this approach may expand access to molecular diagnostics in resource-limited regions and strengthen local capacities for genetic screening, counselling, and public health strategies in areas heavily affected by SCD.
Zitieren
APA
Grunder, F., Hämmerli, A., Bokembya, C. I. N., Hennart, S., Helmers, M., Porret, N. A., Graz, B., Ouabo, C. C., & Abriel, H. (2026). A portable molecular laboratory for rapid genotyping in the field: a feasibility study for sickle cell disease. Frontiers in Genetics, 17. https://doi.org/10.3389/fgene.2026.1999369
Vancouver
Grunder F, Hämmerli A, Bokembya CIN, Hennart S, Helmers M, Porret NA, et al. A portable molecular laboratory for rapid genotyping in the field: a feasibility study for sickle cell disease. Frontiers in Genetics. 2026;17. doi:10.3389/fgene.2026.1999369
BibTeX
@article{Grunder2026,
author = {Grunder, Fabienne and Hämmerli, Anne-Flore and Bokembya, Claude Isofa Nkanga and Hennart, Stéphen and Helmers, Muriel and Porret, Naomi Azur and Graz, Bertrand and Ouabo, Cécile Choudja and Abriel, Hugues},
title = {A portable molecular laboratory for rapid genotyping in the field: a feasibility study for sickle cell disease},
journal = {Frontiers in Genetics},
year = {2026},
volume = {17},
doi = {10.3389/fgene.2026.1999369}
}
EUVIMED